SI Stock Forecast & Price Target

Shoulder Innovations Inc. has demonstrated significant growth in its surgeon customer base, with a year-over-year increase of approximately 61.4%, highlighting the company's effective customer acquisition strategy. The company reported total revenue of $11.8 million for the fourth quarter, reflecting a substantial 58% increase and surpassing estimates by $1.8 million, which has contributed to an optimistic revenue outlook for the upcoming year. Furthermore, management's raised sales projections for 2025 to a range of $45 million to $46 million, coupled with the accelerated adoption of its products among surgeons, positions Shoulder Innovations favorably within the medical technology sector.

Shoulder Innovations Inc. reported an adjusted EBITDA loss of $7.5 million, which was approximately $400,000 worse than initial projections, indicating challenges in managing expenses relative to revenue generation. Additionally, the company experienced a significant EBITDA loss of $23.6 million, compounded by higher-than-expected selling, general, and administrative expenses driven by increased headcount and legal costs. Furthermore, market risks such as slower product adoption, lower growth rates in the shoulder market, and potential operating expenses exceeding forecasts contribute to a negative outlook for the company's financial performance.